Skip to content

Laborie Medical Technologies

Request correction

Laborie is a global medical technology company specializing in Gastroenterology, Urology, and Maternal & Child Health.

Last updated September 11, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Laborie Medical Technologies is a global medical technology company specializing in Gastroenterology, Urology, and Maternal & Child Health. It manufactures and delivers diagnostic and therapeutic products that help clinicians and hospitals improve patient outcomes. The company is privately owned by Patricia Industries, a division of the Investor AB network.

History

Laborie is a global medical technology company specializing in Gastroenterology, Urology, and Maternal & Child Health. It manufactures and delivers diagnostic and therapeutic products that help clinicians and hospitals improve patient outcomes through progressive technology and best practices. The company is privately owned by Patricia Industries, a division of the Investor AB network, whose owners take a long-term investment approach.

Products and positioning

A Leader in Medical Devices; market-leading experts in its areas of specialty.

  • Urology & Urogynecology portfolio

    Full portfolio of diagnostic and treatment solutions for lower urinary tract symptoms.

  • Gastroenterology portfolio

    Diagnostic and therapeutic solutions designed for patient-centered GI care.

  • Maternal & Child Health portfolio

    Clinician-preferred medical devices for labor & delivery care, including the Koala® Intrauterine Pressure Catheter and Kiwi® Vacuum-Assisted Delivery System.

Recent events

  • Reported

    Laborie acquires exclusive Optilume license[6]

    Laborie announced that it had acquired a perpetual, exclusive license to the Optilume Urethral Drug Coated Balloon; the announcement said the acquisition followed FDA approval in early December.

  • Reported

    LABORIE agrees to acquire Clinical Innovations[7]

    Clinical Innovations signed a definitive agreement to be acquired by LABORIE Medical Technologies for an enterprise value of $525 million. The deal was expected to close in early 2020.

Read more

Sources7 sources

Cite this profile: Cite the canonical profile. /brand-wiki/laborie-medical-technologies · Editorial policy · How profiles are compiled